Co-Authors
This is a "connection" page, showing publications co-authored by Lokesh Sharma and De Chang.
Connection Strength
2.611
-
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA. 2020 03 17; 323(11):1092-1093.
Score: 0.872
-
Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19. J Inflamm Res. 2021; 14:1207-1216.
Score: 0.234
-
Does inflammation help during COVID-19? ERJ Open Res. 2020 Oct; 6(4).
Score: 0.227
-
Host tolerance contributes to persistent viral shedding in COVID-19. EClinicalMedicine. 2020 Sep; 26:100529.
Score: 0.226
-
Reply to Suri et al.: COVID-19 Real-Time RT-PCR: Does Positivity on Follow-up RT-PCR Always Imply Infectivity? Am J Respir Crit Care Med. 2020 07 01; 202(1):148.
Score: 0.223
-
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2585-2591.e1.
Score: 0.222
-
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Am J Respir Crit Care Med. 2020 05 01; 201(9):1150-1152.
Score: 0.220
-
Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020 03; 8(3):e13.
Score: 0.217
-
The kinetics of humoral response and its relationship with the disease severity in COVID-19. Commun Biol. 2020 12 11; 3(1):780.
Score: 0.057
-
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Front Immunol. 2020; 11:586572.
Score: 0.057
-
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020 07 28; 71(15):778-785.
Score: 0.056